Feb 26, 2018 ... Martin v. Bayer HealthCare Pharmaceuticals, Inc. et al (1:18-cv-01747), New York Southern District Court, Filed: 02/26/2018 - PacerMonitor Mobile Federal and Bankruptcy Court PACER Dockets.
Feb 26, 2018 ... Neely v. Bayer HealthCare Pharmaceuticals, Inc. et al (1:18-cv-01750), New York Southern District Court, Filed: 02/26/2018 - PacerMonitor Mobile Federal and Bankruptcy Court PACER Dockets.
Jun 30, 2016 ... BAYER HEALTHCARE PHARMACEUTICALS INC. v. RJ HEALTH SYSTEMS INTERNATIONAL, LLC., No. 2:2015cv06952 - Document 43 (D.N.J. 2016) case opinion from the District of New Jersey US Federal District Court.
Nov 20, 2017 ... 2 in the U.S. District Court for the Eastern District of Pennsylvania against Bayer Healthcare Pharmaceuticals Inc. alleging negligence and other counts under case number 2:17-cv-04936-JP, U.S. District Court for the Eastern District of Pennsylvania. Additionally there are other multi-plaintiff actions against ...
Jul 27, 2015 ... Plaintiff Bayer. Healthcare Pharmaceuticals Inc. ("Bayer'') is the holder of approved New Drug. Application ("NDA") No. 21-470 for Finacea® Gel, 15%, indicated for topical treatment of inflammatory ... manufacture, use, sell, offer for sale and/or import a generic Azelaic Acid Gel, 15% formulation with a.
Law360, New York (September 21, 2015, 4:39 PM EDT) -- Bayer HealthCare Pharmaceuticals Inc. filed suit in New Jersey federal court Friday alleging that a drug-information company conflated prices of the drugmaker's Mirena intrauterine device and Actavis PLC's Liletta, creating potential reimbursement gaps and forcing ...
Law360, New York (January 23, 2017, 2:13 PM EST) -- RJ Health Systems International LLC must face Bayer HealthCare Pharmaceuticals Inc.'s suit alleging that the drug information company falsely listed the price of Bayer's intrauterine device Mirena as nearly $200 less than it actually costs, leading to lost income for the ...
Dec 17, 2014 ... Mike Townsend sued Bayer HealthCare Pharmaceuticals (Bayer) alleging Bayer wrongfully terminated him in violation of the whistleblower protection ... he and his fellow sales representatives continued to seek guidance from Bayer on how to deal with physicians submitting Medicaid claims for the price of ...
Overview. Cooley delivered a significant win for longtime client Onyx Pharmaceuticals, Inc. in a dispute with its partner, the international pharmaceutical company, Bayer. ... 31, 2011. Bayer could also make future payments to Onyx of up to an aggregate of $15 million in 2012-2013 based on future Nexavar pricing in Japan.